Kezar life sciences, inc. (KZR)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16
Cash flows from operating activities:
Net loss

-35,087

-23,167

-8,517

-8,990

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

1,301

690

175

154

Stock-based compensation

4,007

1,993

203

128

Amortization of premiums and discounts on marketable securities

979

476

-

-

Loss on disposal of property and equipment

-

-106

-

-

Changes in operating assets and liabilities
Prepaid expenses and other current assets

553

1,136

543

598

Other assets

-

-61

282

-

Accounts payable and accrued liabilities

2,208

1,440

844

-469

Operating lease liabilities and other liabilities

-774

-8

6

-

Deferred rent

-

295

-5

-15

Net cash used in operating activities

-29,877

-20,792

-8,109

-9,760

Cash flows from investing activities:
Purchases of property and equipment

607

1,120

389

132

Purchases of marketable securities

102,255

119,244

-

-

Maturities of marketable securities

123,281

36,450

-

-

Proceeds from sale of property and equipment

-

10

-

-

Net cash (used in) provided by investing activities

20,419

-83,904

-389

-132

Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs

-

77,695

-

-

Proceeds from issuance of preferred stock, net of issuance costs

-

-

49,755

-

Proceeds from issuance of common stock under employee stock incentive plans

272

218

-

-

Proceeds from the exercise of stock options

-

-

-

36

Net cash provided by financing activities

272

77,913

49,755

36

Effect of exchange rate changes on cash and cash equivalents

-45

-81

29

-150

Net increase (decrease) in cash and cash equivalents

-9,231

-26,864

41,286

-10,006

Supplemental disclosures of noncash investing and financing information:
Reclassification of employee stock liability to equity upon vesting

50

69

16

-

Addition of tenant improvement paid by landlord

-

2,703

464

-

Purchase of property and equipment in accounts payable

-

38

-

-

Conversion of redeemable convertible preferred stock into common stock

-

77,931

-

-